QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MRVI

QT68Maravai LifeSciences Holdings, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
5.20
-0.02-0.38%
OverviewShort InterestFilings
MRVIQT68Maravai LifeSciences Holdings, Inc.·NASDAQ
OverviewShort InterestFilings
5.20-0.38%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.73
Insider Own-
Shs Outstand258.19M
Perf Week-0.19%
Market Cap1.44BForward P/E-EPS next Y-0.09Insider Trans-0.02%Shs Float-Perf Month23.22%
Enterprise Value1.55BPEG-EPS next Q-0.05Inst Own-Short Float-Perf Quarter71.62%
Income-197248698.00P/S7.04EPS this Y84.37%Inst Trans-Short Ratio-Perf Half Y44.85%
Sales204.73MP/B3.61EPS next Y18.67%ROA-14.66%Short Interest-Perf YTD60.00%
Book/sh1.43P/C-EPS next 5Y-ROE-44.72%52W High5.32 -2.26%Perf Year148.80%
Cash/sh0.64P/FCF-EPS past 3/5Y-ROIC6.48%52W Low1.99 161.31%Perf 3Y-
Dividend Est.-EV/EBITDA-14.89Sales past 3/5Y-40.50% -8.12%Gross Margin29.00%Volatility3.64% 3.54%Perf 5Y-
Dividend TTM-EV/Sales7.56EPS Y/Y TTM81.90%Oper. Margin21.93%ATR (14)0.26Perf 10Y-
Dividend Ex-Date-Quick Ratio4.96Sales Y/Y TTM-20.85%Profit Margin-51.07%RSI (14)68.24Recom2.57
Dividend Gr. 3/5Y-Current Ratio5.91EPS Q/Q112.50%SMA206.89%Beta1.79Target Price6.00
Payout0.00%Debt/Eq1.28Sales Q/Q40.43%SMA5022.91%Rel Volume3.14Prev Close5.22
Employees570LT Debt/Eq0.08EarningsAug 10SMA20048.07%Avg Volume2.68MPrice5.20
IPO DateNov 20, 2020Option/ShortYes / YesEPS/Sales Surpr.120.00% 24.53%Net Debt/EBITDA-1.01Volume8,406,104Change-0.38%
Analyst Ratings
DateActionAnalystRatingTarget
May-08-26ReiteratedDeutsche BankBuy$4.50 → $6.00
Dec-15-25ReiteratedWells FargoOverweight$4.50
Mar-21-25ReiteratedStifel Nicolaus$10 → $5.00
Feb-26-25DowngradeBairdOutperform → Neutral
Dec-05-24DowngradeGoldman SachsNeutral → Sell
Nov-08-24DowngradeWilliam BlairOutperform → Market Perform
Aug-13-24DowngradeMorgan StanleyOverweight → Equal Weight
May-09-24ReiteratedRobert W. Baird$8.00 → $10
Dec-12-23UpgradeB of A SecuritiesNeutral → Buy
Aug-08-23DowngradeKeybancOverweight → Sector Weight
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue205186259
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A146152151
Gross Profit6033108
Selling, General and Administrative Excl. Other159171162
Research and Development232319
Other Operating Expense-168-154163
Operating Income44-7-236
Interest Expense272748
Unusual Expense
———
Non-Operating Income (Expense)208201-22
Net Income Before Taxes-189-235-261
Income Taxes-4-4-2
Consolidated Net Income-106-131-145
Net Income From Continuing Operations-184-231-260
Net Income-106-131-145
EPS (Recurring)-0.73-0.91-1.05
EPS (Basic, Before Extraordinaries)-0.73-0.91-1.05
EPS (Diluted)-0.73-0.91-1.05
EBITDA-104-147-157
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.702.53—
Gross Margin29.2717.7441.70
Operating Margin21.46-3.76-91.12
Net Margin-51.71-70.43-55.98
Shares Outstanding146145138
Market Capitalization759471—
Operating Lease Expense
———
Insider Trading Volume
$5.86$5.47$5.09$4.71$4.32● Close Price0.00M0.38M0.76M1.13M1.51MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
ORESHACK KURTGeneral CounselJun 10 '26Sale5.1025,000127,500335,767Jun 10 12:00 AM
ORESHACK KURTGeneral CounselJun 09 '26Sale5.0625,000126,500360,767Jun 10 12:00 AM
LUCIER GREGORY TDirectorDec 08 '25Buy3.6748,528178,098155,123Dec 09 12:00 AM
LUCIER GREGORY TDirectorDec 05 '25Buy3.7051,472190,446106,595Dec 09 12:00 AM
Brust BerndChief Executive OfficerNov 13 '25Buy3.25216,212702,689466,771Nov 17 12:00 AM
Brust BerndChief Executive OfficerNov 12 '25Buy3.2193,358299,679250,559Nov 13 12:00 AM
Brust BerndChief Executive OfficerNov 11 '25Buy3.24157,201509,331157,201Nov 13 12:00 AM
ORESHACK KURTGeneral CounselJan 31 '25Sale5.0325,000125,750167,618Jan 31 12:00 AM
DeFord John ADirectorNov 12 '24Buy5.7517,500100,62570,046Nov 14 12:00 AM
HULL CARLSee RemarksNov 11 '24Buy5.64175,000987,000175,000Nov 12 12:00 AM
GTCR INVESTMENT XI LLCdirector, 10 percent owner:May 28 '24Sale9.819,940,97497,570,66020,150,005May 30 12:00 AM
HULL CARLChief Executive OfficerNov 25 '20Buy26.9435,000942,90035,000Nov 30 12:00 AM
Hance Robert BDirectorNov 24 '20Buy27.0010,000270,00021,852Nov 25 12:00 AM
GRAY SUSANNAHDirectorNov 24 '20Buy27.0020,000540,00031,852Nov 25 12:00 AM
SELLERS LISASee RemarksNov 24 '20Buy27.0018,888509,97618,888Nov 25 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR